To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TADA2ATABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
198 supporting clones for gene TADA2A back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AL582905 B cells from Burkitt lymphoma .a 1 to 1135 1 to 1131   tiling clone,   1129/1131
(99 %)
23 diff
(98.0 %id)
AL526501 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 14 to 966 1 to 951   tiling clone,   951/955
(99 %)
6 diff
(99.4 %id)
BX404166 neuroblastoma .a 32 to 1049 1 to 1021   tiling clone,   1019/1021
(99 %)
5 diff
(99.6 %id)
AL582853 B cells from Burkitt lymphoma .a 1223 to 2223 1006 to 1   tiling clone,   1006/1006
(100 %)
44 diff
(95.7 %id)
AL562691 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1339 to 2273 929 to 1   tiling clone,   929/929
(100 %)
34 diff
(96.4 %id)
AL699917 human skeletal muscle .a 1423 to 2102 1 to 686   tiling clone,   686/686
(100 %)
5 diff
(99.3 %id)
BF316236 brain, neuroblastoma .a 1564 to 2062 1 to 496       496/785
(63 %)
27 diff
(96.6 %id)
CD673263 eye, Iris .a 1644 to 2027 1 to 386   tiling clone,   386/387
(99 %)
5 diff
(98.8 %id)
BX411878 neuroblastoma .a 1650 to 2285 645 to 7   tiling clone,   639/882
(72 %)
13 diff
(98.6 %id)
AK022767   .b 1 to 1827 3 to 1829 P6S M115V tiling clone, available from FLJ,   1829/1829
(100 %)
6 diff
(99.7 %id)
AU126440   .b 1 to 808 3 to 817   capped   816/852
(95 %)
22 diff
(97.5 %id)
DA346050 substantia nigra .b 1 to 592 2 to 593   tiling clone, capped   592/592
(100 %)
0 diff
(100 %id)
NM_001488.3   .b 2 to 1839 1 to 1838 exact RefSeq, AAA   1838/1838
(100 %)
0 diff
(100 %id)
BG427977 Kidney .b 26 to 751 1 to 729       729/729
(100 %)
10 diff
(98.7 %id)
BQ900440 eye, retinoblastoma .b 47 to 860 24 to 837   tiling clone,   814/837
(97 %)
7 diff
(99.2 %id)
CD101741 Human Placenta, placenta .c 1 to 705 24 to 732   tiling clone,   709/779
(91 %)
12 diff
(98.5 %id)
NM_001166105.1   .c 13 to 1642 1 to 1630 exact RefSeq, AAA   1630/1630
(100 %)
0 diff
(100 %id)
DA244842 brain .c 14 to 586 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA908967   .c 14 to 554 2 to 542   capped   541/541
(100 %)
3 diff
(99.5 %id)
DB168688 kidney, tumor tissue .c 14 to 576 2 to 564   capped   563/563
(100 %)
2 diff
(99.7 %id)
DA087253 cerebellum .c 15 to 594 2 to 582   capped   581/581
(100 %)
4 diff
(99.4 %id)
DT217246 brain .c 15 to 705 1 to 691       691/700
(98 %)
1 diff
(99.9 %id)
DA331601 hippocampus .c 16 to 591 2 to 579   capped   578/578
(100 %)
4 diff
(99.4 %id)
DB115580 thymus .c 16 to 577 2 to 564   capped   563/563
(100 %)
3 diff
(99.5 %id)
DA113380 cerebellum .c 17 to 611 2 to 596   capped   595/595
(100 %)
2 diff
(99.7 %id)
DA219280 brain .c 17 to 569 2 to 554   capped   553/553
(100 %)
2 diff
(99.7 %id)
DA327622 hippocampus .c 17 to 270 2 to 255   capped   254/254
(100 %)
2 diff
(99.3 %id)
CD703986 normal nasopharynx .c 17 to 141 15 to 139       125/139
(89 %)
7 diff
(95.0 %id)
DA868328 Prostate .c 17 to 587 2 to 573   capped   572/573
(99 %)
3 diff
(99.5 %id)
DA788662 brain .c 18 to 594 2 to 579   capped   578/578
(100 %)
3 diff
(99.5 %id)
BG942433 blood .c 23 to 107 1 to 85       85/85
(100 %)
3 diff
(96.5 %id)
BX364222   .c 23 to 416 1 to 396       396/396
(100 %)
3 diff
(99.3 %id)
CD639067 pooled .c 28 to 716 1 to 690       690/743
(92 %)
13 diff
(98.3 %id)
TI_57239986   .c 33 to 761 33 to 761       729/761
(95 %)
11 diff
(98.6 %id)
BI916525 brain .c 34 to 761 1 to 729       729/729
(100 %)
7 diff
(99.1 %id)
AU099905   .c 34 to 333 1 to 300       300/300
(100 %)
7 diff
(97.7 %id)
DA643789   .c 35 to 578 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DB146708 thymus .c 35 to 491 2 to 459   capped   458/458
(100 %)
3 diff
(99.4 %id)
BU567961 testis .c 40 to 816 1 to 782       782/815
(95 %)
14 diff
(98.3 %id)
DB462448 testis .c 51 to 520 1 to 471       471/471
(100 %)
3 diff
(99.4 %id)
DA733868   .c 52 to 687 2 to 637   capped   636/729
(87 %)
13 diff
(98.3 %id)
DA815661   .c 52 to 618 2 to 568   capped   567/573
(98 %)
3 diff
(99.5 %id)
DA186004 amygdala .c 55 to 590 2 to 537   capped   536/536
(100 %)
2 diff
(99.7 %id)
T91418 liver and spleen .c 64 to 445 1 to 387       387/388
(99 %)
14 diff
(96.4 %id)
BE829942 lung_tumor .c 66 to 185 122 to 4       119/127
(93 %)
0 diff
(100 %id)
CD709492 normal nasopharynx .c 72 to 474 17 to 418       402/418
(96 %)
7 diff
(98.4 %id)
AF064094   .c 75 to 1751 10 to 1686 P6S W185R D304N D342G     1677/1691
(99 %)
14 diff
(99.2 %id)
BC011753 Muscle, rhabdomyosarcoma .c 75 to 1642 10 to 1577 P6S tiling clone, available from MGC, AAA   1568/1577
(99 %)
6 diff
(99.7 %id)
AL711128 human skeletal muscle .c 80 to 459 1 to 380       380/380
(100 %)
3 diff
(99.3 %id)
BE255417 eye, retinoblastoma .c 86 to 695 1 to 612       612/613
(99 %)
9 diff
(98.6 %id)
BX362438   .c 88 to 916 1 to 829       810/829
(97 %)
17 diff
(98.0 %id)
BG942347 blood .c 146 to 570 1 to 426       426/426
(100 %)
2 diff
(99.6 %id)
CU445986 epidermis .c 155 to 456 22 to 323       302/337
(89 %)
7 diff
(98.0 %id)
CU453338 epidermis .c 155 to 456 40 to 341       302/355
(85 %)
7 diff
(98.1 %id)
TI_1948078984   .c 165 to 990 122 to 938       817/1098
(74 %)
33 diff
(97.0 %id)
TI_1948078985   .c 165 to 1069 117 to 1019       903/1368
(66 %)
18 diff
(98.7 %id)
TI_1948079325   .c 165 to 997 124 to 956       800/1125
(71 %)
33 diff
(97.1 %id)
TI_1948079326   .c 165 to 1065 121 to 1022   AAA   902/1391
(64 %)
17 diff
(98.8 %id)
TI_1948079674   .c 165 to 994 125 to 951       827/1115
(74 %)
29 diff
(97.4 %id)
TI_1948079675   .c 165 to 1202 121 to 1168       1046/1387
(75 %)
64 diff
(95.4 %id)
TI_1948080029   .c 165 to 774 124 to 733       610/1076
(56 %)
16 diff
(98.6 %id)
TI_1948080030   .c 165 to 1070 117 to 1021       905/1381
(65 %)
20 diff
(98.6 %id)
TI_1948104022   .c 165 to 885 120 to 844       725/1453
(49 %)
20 diff
(98.7 %id)
CV025625 mixed .c 174 to 802 1 to 629       629/629
(100 %)
2 diff
(99.7 %id)
CV028359 mixed .c 174 to 803 1 to 630       630/630
(100 %)
1 diff
(99.9 %id)
TI_1948103875   .c 175 to 772 130 to 727       601/1449
(41 %)
33 diff
(97.8 %id)
DA205189 brain .c 223 to 763 2 to 543   capped   542/542
(100 %)
1 diff
(99.9 %id)
AW298572   .c 324 to 845 525 to 5   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 523/525
(99 %)
0 diff
(100 %id)
AA297238   .c 355 to 611 1 to 258       258/272
(94 %)
2 diff
(99.3 %id)
AW962488   .c 356 to 876 1 to 519       519/543
(95 %)
16 diff
(97.1 %id)
AA719333 pineal gland .c 365 to 836 472 to 1       472/477
(98 %)
3 diff
(99.4 %id)
BE739127 hypernephroma, Kidney .c 375 to 591 1 to 215       215/239
(89 %)
7 diff
(97.1 %id)
AF069732   .c 414 to 1505 1 to 1092       1092/1092
(100 %)
2 diff
(99.9 %id)
BF755322 colon .c 452 to 802 1 to 352       352/352
(100 %)
6 diff
(98.3 %id)
TI_1948080031   .c 461 to 1501 1167 to 122       1055/1271
(83 %)
95 diff
(92.6 %id)
DA708503   .c 462 to 1033 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA708523   .c 462 to 950 2 to 494   capped   493/493
(100 %)
4 diff
(99.2 %id)
BM917565 blood, natural killer cells, cell line .c 530 to 1297 22 to 793       772/1152
(67 %)
21 diff
(98.2 %id)
TI_1948079327   .c 609 to 1501 1020 to 121       909/1258
(72 %)
67 diff
(94.7 %id)
TI_1948078986   .c 610 to 1501 1018 to 120       908/1251
(72 %)
68 diff
(94.6 %id)
TI_1948079677   .c 610 to 1501 1021 to 121       910/1153
(78 %)
82 diff
(92.9 %id)
TI_1948079676   .c 612 to 1501 1021 to 121       910/1308
(69 %)
62 diff
(95.3 %id)
CF146329 CNCAP(3)T-225 cell line, Prostate .c 616 to 1341 9 to 731       726/731
(99 %)
11 diff
(98.5 %id)
TI_154178758   .c 616 to 1478 73 to 928       858/858
(100 %)
17 diff
(98.1 %id)
TI_1948078987   .c 626 to 1501 997 to 120       887/1121
(79 %)
82 diff
(92.7 %id)
BE396288 endometrium, adenocarcinoma cell line, uterus .c 656 to 1017 49 to 410       362/411
(88 %)
7 diff
(98.3 %id)
DA044801 bladder .c 659 to 1136 2 to 481   capped   480/480
(100 %)
2 diff
(99.6 %id)
DA792812 brain .c 659 to 1199 2 to 542   capped   541/542
(99 %)
1 diff
(99.9 %id)
BF081461 amnion_normal .c 703 to 872 28 to 201       174/201
(86 %)
16 diff
(92.1 %id)
TI_1948079328   .c 704 to 1501 923 to 120       813/1131
(71 %)
75 diff
(93.4 %id)
TI_1948080032   .c 771 to 1501 850 to 104       609/1131
(53 %)
82 diff
(92.8 %id)
BX280113 cervical carcinoma cell line, cervix .c 795 to 1266 1 to 474       474/474
(100 %)
4 diff
(99.2 %id)
BI334030 cervical carcinoma cell line, cervix .c 795 to 1617 1 to 829       829/829
(100 %)
14 diff
(98.4 %id)
BI333991 cervical carcinoma cell line, cervix .c 795 to 1591 1 to 801       801/996
(80 %)
14 diff
(98.6 %id)
T91332 liver and spleen .c 846 to 1299 456 to 2       455/456
(99 %)
8 diff
(98.3 %id)
DR979005 placenta .c 874 to 972 98 to 1       98/100
(98 %)
6 diff
(94.0 %id)
AA280181 germinal center B cell .c 915 to 1362 1 to 445       445/445
(100 %)
3 diff
(99.4 %id)
DB138358 thymus .c 1117 to 1654 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
BF793504 adrenal cortex carcinoma, cell line, adrenal gland .c 1238 to 1751 12 to 525       514/525
(97 %)
0 diff
(100 %id)
AU150932   .c 1244 to 1754 509 to 1   tiling clone,   509/564
(90 %)
10 diff
(98.3 %id)
NM_133439.2   .d 1 to 1304 1 to 1304 exact RefSeq, AAA   1304/1304
(100 %)
0 diff
(100 %id)
BC001172 Eye, retinoblastoma .d 271 to 1304 10 to 1043 P6S H117Y tiling clone, available from MGC, AAA   1034/1043
(99 %)
7 diff
(99.4 %id)
TI_1948103743   .d 361 to 1004 121 to 767   fully sequenced,   647/767
(84 %)
9 diff
(98.9 %id)
CA423000 cell lines, Chondrosarcoma .d 635 to 1302 687 to 19   tiling clone, AAA   669/669
(100 %)
1 diff
(99.9 %id)
AI000805 breast .d 856 to 1302 447 to 1       447/447
(100 %)
0 diff
(100 %id)
TI_1948103744   .d 943 to 1291 468 to 120   fully sequenced,   349/468
(74 %)
0 diff
(100 %id)
DA386952 thalamus .e 1 to 575 2 to 576   tiling clone, capped   575/575
(100 %)
1 diff
(99.9 %id)
AA297862   .e 245 to 531 1 to 287       287/287
(100 %)
0 diff
(100 %id)
TI_57170172   .e 479 to 1312 112 to 946 E8X F23L A24H S25L T26P ... tiling clone,   835/946
(88 %)
11 diff
(98.9 %id)
BI825287 brain, medulla .e 480 to 1312 1 to 834 E8X F23L A24H S25L T26P ... tiling clone,   834/834
(100 %)
5 diff
(99.5 %id)
CR615572 B cells (Ramos cell line) Cot 25-normalized .f 1 to 1305 2 to 1306 exact tiling clone,   1306/1306
(100 %)
0 diff
(100 %id)
BX370711   .f 1 to 919 2 to 920       920/920
(100 %)
8 diff
(99.2 %id)
BX374302   .f 551 to 1305 763 to 1       763/881
(86 %)
19 diff
(97.9 %id)
CB529670 Aveolar Macrophage, lung .f 831 to 1496 684 to 19   tiling clone, AAA   666/666
(100 %)
1 diff
(99.9 %id)
BE294059 muscle, rhabdomyosarcoma .f 916 to 1289 1 to 376       376/486
(77 %)
6 diff
(98.8 %id)
FN169400 breast carcinoma .f 936 to 1030 92 to 1     Submitted on the opposite strand 92/95
(96 %)
4 diff
(95.8 %id)
AI655771 pooled germ cell tumors .f 939 to 1308 376 to 7       370/532
(69 %)
0 diff
(100 %id)
AA856985 pharynx, squamous cell carcinoma .f 956 to 1308 353 to 1       353/353
(100 %)
0 diff
(100 %id)
AA811044 germinal center B cell .f 1052 to 1299 287 to 39   AAA   249/249
(100 %)
4 diff
(98.4 %id)
FN082747 breast carcinoma .f 1055 to 1157 1 to 102       102/102
(100 %)
3 diff
(97.1 %id)
BI770950 pooled lung and spleen .f 1310 to 1795 1 to 492   tiling clone,   492/492
(100 %)
19 diff
(96.2 %id)
TI_57183039   .f 1310 to 1795 35 to 526       492/526
(93 %)
6 diff
(98.9 %id)
AL558859 T cells from T cell leukemia .f 1336 to 2186 1 to 848   tiling clone, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 848/848
(100 %)
24 diff
(97.2 %id)
AK123123 cerebellum .f 1866 to 3793 1 to 1929   tiling clone, available from FLJ,   1929/1929
(100 %)
3 diff
(99.9 %id)
DA068344 cerebellum .f 1867 to 2429 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DB527874 testis .f 1880 to 2334 1 to 455   tiling clone, AAA Submitted on the opposite strand 455/455
(100 %)
1 diff
(99.8 %id)
BQ068240 brain .f 1962 to 2770 7 to 832       826/1010
(81 %)
30 diff
(97.1 %id)
DB297391 cerebellum .f 3323 to 3793 471 to 1       471/471
(100 %)
3 diff
(99.4 %id)
DA833538 placenta .g 1 to 783 2 to 794   tiling clone, capped   793/795
(99 %)
12 diff
(98.5 %id)
R67748 placenta .g 1096 to 1482 1 to 393   tiling clone,   393/395
(99 %)
5 diff
(98.8 %id)
BQ010696 placenta .g 1204 to 1626 441 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 424/424
(100 %)
4 diff
(99.1 %id)
DB380324 placenta .g 1224 to 1626 402 to 1       402/413
(97 %)
5 diff
(98.8 %id)
DA076519 cerebellum .g 1247 to 1803 2 to 566   capped   565/565
(100 %)
9 diff
(98.5 %id)
AI201495 Prostate .g 1276 to 1626 350 to 1       350/350
(100 %)
5 diff
(98.6 %id)
AA781669   .g 1311 to 1626 317 to 1       317/317
(100 %)
2 diff
(99.4 %id)
AA863195 2 pooled tumors (clear cell type), Kidney .g 1334 to 1628 299 to 5       295/299
(98 %)
0 diff
(100 %id)
CR979863 T-Lymphocytes .g 1387 to 2280 1 to 899   tiling clone,   899/899
(100 %)
11 diff
(98.8 %id)
AI382463 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g 1480 to 1626 170 to 23   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 148/148
(100 %)
3 diff
(98.0 %id)
CB215685 normal endometrium, late proliferativephase, cycle day 13, uterus .g 1548 to 2211 1 to 664       664/664
(100 %)
0 diff
(100 %id)
CD559085 White Matter .g 1643 to 2449 1 to 814       814/882
(92 %)
12 diff
(98.7 %id)
CD518020 White Matter .g 1644 to 2062 29 to 448       420/767
(54 %)
5 diff
(99.4 %id)
H47374 liver and spleen .g 1645 to 1968 1 to 323     Submitted on the opposite strand 323/323
(100 %)
4 diff
(98.8 %id)
BF061538 pooled .g 1651 to 2125 475 to 1       475/475
(100 %)
1 diff
(99.8 %id)
R74011 breast .g 1734 to 2005 1 to 272       272/272
(100 %)
0 diff
(100 %id)
BI770731 pooled lung and spleen .g 1908 to 2576 1 to 673       673/673
(100 %)
8 diff
(98.9 %id)
TI_57184095   .g 1908 to 2576 28 to 700       673/700
(96 %)
6 diff
(99.2 %id)
AL119944 amygdala .g 1916 to 2441 1 to 526   tiling clone,   526/527
(99 %)
1 diff
(99.9 %id)
R00779 liver and spleen .g 2009 to 2307 12 to 315       304/318
(95 %)
13 diff
(96.0 %id)
BF338136 brain, glioblastoma with EGFR amplification .g 2091 to 2859 1 to 763       763/771
(98 %)
12 diff
(98.5 %id)
TI_157601742   .g 2264 to 3085 843 to 28   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 816/938
(86 %)
24 diff
(97.5 %id)
TI_149272949   .g 2315 to 3085 851 to 86   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 766/953
(80 %)
12 diff
(98.8 %id)
TI_149306824   .g 2315 to 3085 854 to 86   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 769/933
(82 %)
8 diff
(99.2 %id)
BX104996 liver and spleen .g 2320 to 3085 780 to 15   tiling clone, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 766/766
(100 %)
1 diff
(99.9 %id)
R09941 liver and spleen .g 2352 to 2691 1 to 351       351/361
(97 %)
18 diff
(95.1 %id)
CF529303 placenta .g 2507 to 3085 596 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 578/578
(100 %)
3 diff
(99.5 %id)
BU686634 lung, Primary Lung Epithelial Cells .g 2507 to 3085 599 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 581/581
(100 %)
2 diff
(99.7 %id)
TI_157602536   .g 2510 to 3085 682 to 104   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 579/1051
(55 %)
9 diff
(99.2 %id)
BM991710 Bone, Subchondral Bone .g 2511 to 2989 496 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 478/480
(99 %)
1 diff
(99.8 %id)
BU675434 lung, Primary Lung Epithelial Cells .g 2513 to 3085 593 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 575/575
(100 %)
3 diff
(99.5 %id)
AA830590 germinal center B cell .g 2562 to 3085 532 to 13   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 520/531
(97 %)
13 diff
(97.6 %id)
AW977586   .g 2579 to 3084 508 to 1     Submitted on the opposite strand 508/508
(100 %)
22 diff
(95.7 %id)
BQ187943 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .g 2608 to 3071 1 to 464       464/464
(100 %)
0 diff
(100 %id)
CF529493 placenta .g 2656 to 3085 448 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 430/430
(100 %)
0 diff
(100 %id)
H47464 liver and spleen .g 2677 to 3086 426 to 1     Submitted on the opposite strand 426/487
(87 %)
13 diff
(97.4 %id)
AW627838 2 pooled high-grade transitional celltumors, genitourinary tract .g 2722 to 3085 365 to 1       365/365
(100 %)
2 diff
(99.5 %id)
AW204052   .g 2768 to 3089 339 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 322/332
(96 %)
0 diff
(100 %id)
AA809900 germinal center B cell .g 2894 to 3085 204 to 13   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 192/192
(100 %)
0 diff
(100 %id)
AI220840 placenta .g 2894 to 3085 192 to 1       192/192
(100 %)
0 diff
(100 %id)
BI910656 leukocyte .h 1 to 829 1 to 825 D2P R3L L4G G5S P6F ... tiling clone,   825/826
(99 %)
13 diff
(98.5 %id)
TI_57237569   .h 1 to 829 32 to 856 D2P R3L L4G G5S P6F ...     825/857
(96 %)
23 diff
(97.4 %id)
BX457860 neuroblastoma .i 1 to 804 1 to 803 A45X E56X D84X A86G Y88D ... tiling clone,   803/803
(100 %)
9 diff
(98.9 %id)
DA327194 hippocampus .j 1 to 560 2 to 561 P6S tiling clone, capped   560/560
(100 %)
1 diff
(99.9 %id)
EB387785 eye, optic nerve .k 1 to 723 1 to 723 exact tiling clone,   723/723
(100 %)
0 diff
(100 %id)
BP872614 embryonal kidney .l 1 to 584 1 to 584 exact tiling clone,   584/584
(100 %)
1 diff
(99.9 %id)
DA405941 thalamus .m 1 to 647 2 to 648 P6S tiling clone, capped   647/647
(100 %)
1 diff
(99.9 %id)
BP377907 uterus .n 1 to 583 1 to 583 F59X K78X V85S tiling clone,   583/583
(100 %)
3 diff
(99.5 %id)
DA803097 brain .o 1 to 489 2 to 491 P6S E33* tiling clone, capped   490/490
(100 %)
2 diff
(99.6 %id)
BP280145   .p 1 to 598 1 to 598   tiling clone,   598/598
(100 %)
4 diff
(99.4 %id)
AA533330 invasive prostate tumor, Prostate .p 528 to 1129 1 to 594   tiling clone,   594/638
(93 %)
22 diff
(96.6 %id)
AW973089   .p 534 to 978 111 to 555       445/557
(79 %)
9 diff
(98.4 %id)
CA395430 eye, RPE/choroid .p 670 to 1105 436 to 1   tiling clone, Submitted on the opposite strand 436/436
(100 %)
4 diff
(99.1 %id)
AL597527   .q 1 to 487 2 to 488       488/488
(100 %)
2 diff
(99.6 %id)
DA402503 thalamus .q 1 to 487 2 to 488   tiling clone, capped   487/487
(100 %)
1 diff
(99.8 %id)
BM906267 ovary (pool of 3) .q 3 to 928 1 to 927 E77G D79* tiling clone,   927/1019
(90 %)
19 diff
(98.2 %id)
AI601135 colon .r 1 to 362 364 to 3 exact tiling clone,   362/364
(99 %)
0 diff
(100 %id)
CD690263 normal nasopharynx .r 316 to 647 22 to 349   tiling clone,   328/349
(93 %)
6 diff
(98.3 %id)
DA709132   .s-u 1 to 561 2 to 562 exact tiling clone, capped   561/561
(100 %)
1 diff
(99.9 %id)
BE158199 head_neck .s-u 47 to 227 1 to 180       180/180
(100 %)
4 diff
(97.8 %id)
AA569437   .t-u 1 to 411 1 to 411 exact tiling clone,   411/411
(100 %)
1 diff
(99.8 %id)
BI030275 marrow .u 1 to 362 360 to 1 A2Q S12X P25X E26K S27* tiling clone,   360/360
(100 %)
3 diff
(99.2 %id)
BI030294 marrow .u 1 to 302 1 to 300 E26K S27* tiling clone,   300/304
(98 %)
3 diff
(99.1 %id)
AL558913 T cells from T cell leukemia Gene TADA2A, variant not shown         This clone was ignored    
AL580627 T cells from T cell leukemia Gene TADA2A, variant not shown         This clone was ignored    
DB325000   Gene TADA2A, variant not shown         Suspected internal deletion, suspected internal deletion, suspected internal deletion, this clone was ignored    
DA746651   Gene TADA2A, variant not shown       capped Suspected internal deletion, suspected internal deletion, suspected internal deletion, this clone was ignored    
AK096371   Gene TADA2A, variant not shown       available from FLJ, Suspected internal deletion, suspected internal deletion, suspected internal deletion, this clone was ignored    
AK225918 synovial membrane Gene TADA2A, variant not shown       AAA This clone was ignored    
DA065610 cerebellum Gene TADA2A, variant not shown       capped Suspected internal deletion, this clone was ignored    
T86621 liver and spleen Gene TADA2A, variant not shown         Suspected internal deletion, this clone was ignored    
T86622 liver and spleen Gene TADA2A, variant not shown         Suspected internal deletion, this clone was ignored    
R91370 liver and spleen Gene TADA2A, variant not shown              
R92623 liver and spleen Gene TADA2A, variant not shown              
AA664041 lung Gene TADA2A, variant not shown         This clone was ignored    
AI082698 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus Gene TADA2A, variant not shown         This clone was ignored    
AI382985 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus Gene TADA2A, variant not shown         Suspected internal deletion, this clone was ignored    
AI379124 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus Gene TADA2A, variant not shown         Suspected internal deletion, this clone was ignored    
AI401487 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus Gene TADA2A, variant not shown         This clone was ignored    
AI969802 pooled germ cell tumors Gene TADA2A, variant not shown         Suspected internal deletion, this clone was ignored    
AI968140 pooled germ cell tumors Gene TADA2A, variant not shown         Suspected internal deletion, this clone was ignored    
BM470857 leiomyosarcoma, uterus Gene TADA2A, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s-u, .t-u, .u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI